News, Analysis, Trends, Management Innovations for
Clinical Laboratories and Pathology Groups

Hosted by Robert Michel

News, Analysis, Trends, Management Innovations for
Clinical Laboratories and Pathology Groups

Hosted by Robert Michel
Sign In

Iranian Study Shows Staggering Carcinogenic Risk in Hospital Laboratories from Occupational Exposure to Deadly Chemicals

Study found highest incidences of occupational carcinogenesis among clinical laboratory and histology technicians, followed by pathologists

It has been known for years that formalin (a form of formaldehyde used as a disinfectant and preservative in the handling of tissues samples in anatomy, pathology, and microbiology labs), as well as xylene and toluene, are dangerous to clinical laboratory workers. Nations around the world have taken steps to minimize exposure to these dangerous chemicals. However, a recent study in Iran found that those measures may not have gone far enough to protect histology and clinical laboratory technicians, pathologists, and medical laboratory scientists.

The study conducted by researchers in the Department of Occupational Health Engineering, School of Public Health, at Tehran University of Medical Sciences, showed that levels of exposure to these chemicals is still significantly higher than recommended, resulting in a higher risk for cancer among lab workers in Iran’s hospitals.

The scientists published their findings in the journal Nature Scientific Reports titled, “Occupational Exposure, Carcinogenic and Non-Carcinogenic Risk Assessment of Formaldehyde in the Pathology Labs of Hospitals in Iran.”

“Employing risk assessment techniques as a complementary tool in monitoring programs for respiratory exposure in the different work setting should be considered to protect the staffs against both non-cancerous and cancer-related hazards,” the study authors wrote.

Lessons learned from the Iranian hospital lab study could benefit clinical laboratory workers in US hospitals and help those who work with formaldehyde, toluene, and xylene worldwide to reduce their chances of developing a vascular condition known as Raynaud’s phenomenon (shown above) which can lead to necrosis and gangrene, as well as other dangerous health conditions affecting the lungs, brain, and other systems and organs in the body. (Photo copyright: Wikipedia.)

Study Details

The Iranian study considered the carcinogenic and non-carcinogenic impact of occupational exposure to formaldehyde in the pathology laboratories of four Tehran hospitals. The researchers “used a quantitative risk assessment method proposed by the United States Environmental Protection Agency (EPA), along with its provided database known as the Integrated Risk Information System (IRIS). Respiratory symptoms were assessed using the American Thoracic Society (ATS) questionnaire,” the study authors wrote in Nature Scientific Reports.

The scientists found that “91.23% of exposure levels in occupational groups exceed the NIOSH [National Institute for Occupational Safety and Health] standard of 0.016 ppm.” They determined that “41.03% of all the studied subjects were in the definite carcinogenic risk range (LCR > 10−4), 23.08% were in the possible carcinogenic risk range (10−5 < LCR < 10−4), and 35.90% were in the negligible risk range (LCR < 10−6),” they wrote.

“The highest index of occupational carcinogenesis was observed in the group of lab technicians with a risk number of 3.7 × 10-4, followed by pathologists with a risk number of 1.7 × 10-4,” the scientists wrote. “Furthermore, 23.08% of the studied subjects were within the permitted health risk range (HQ < 1.0), while 76.92% were within the unhealthy risk range (HQ > 1.0),” they added.

“Formaldehyde exhibits high solubility in water and is rapidly absorbed by the nasal cavity, sinuses, throat, and mucous membrane of the upper respiratory tract upon exposure,” the study authors wrote. “Consequently, due to the elevated potential for both carcinogenic and non-carcinogenic formaldehyde exposure among pathology staff—particularly laboratory technicians—the implementation of management measures … becomes imperative to lower the exposure levels of all employees below permissible limits.”

Those management measures include:

  • “Strict guideline adherence and safe work protocols,
  • “Increasing staff numbers to decrease exposure duration,
  • “Adoption of engineering solutions such as localized ventilation systems, and
  • “Use of respiratory protective equipment during sample handling and tissue processing.”

Previous Reports on Exposure Risk to Clinical Lab Workers

The knowledge of the danger behind these chemicals isn’t new.

In “National Academy of Sciences Confirms That Formaldehyde Can Cause Cancer in a Finding That Has Implications for Anatomic Pathology and Histology Laboratories,” Dark Daily covered how, in 2011, the US Department of Health and Human Services (HHS) National Toxicology Program’s (NTP) “Report on Carcinogens” was the first instance where formaldehyde was upgraded to “known to be a human carcinogen.”

In 2017, a pathology lab in Auckland, New Zealand, lost its accreditation because formaldehyde levels were so high the lab had to be evacuated nearly every day, The New Zealand Herald reported.

And in “Health of Pathology Laboratory Technicians at Risk from Common Solvents like Xylene and Toluene,” we reported on a 2011 study conducted in Wellington, New Zealand, that linked exposure to these chemicals with increased auto immune connective tissue diseases, notably doubling likelihood of developing Raynaud’s phenomenon.

“In epidemiological studies on industrial workers, pathologists and anatomists, the relationship between exposure to formaldehyde and an increased risk of various types of cancer including nasal cavity, nasopharynx, lung, brain, pancreas, prostate, colon and atopic lymphoma system has been determined,” the Iranian scientists wrote in Nature Scientific Reports.

Call for Stronger Regulations

“The Food and Drug Administration (FDA), the Consumer Product Safety Commission (CPSC), and the Environmental Protection Agency have expressed serious concern about the carcinogenicity of formaldehyde,” the Iranian scientists noted, adding that “the potential carcinogenic risk to humans has been studied in a number of cohort and case-control studies.”

There is room for more studies looking at the health effects of exposure to these chemicals among lab workers, as well as continued evaluation of the risks and preventative measures that could be taken. Perhaps tightened regulations will make its way to US labs, echoing more stringent ones of the European Union.

“It is imperative to implement control measures across various hospital departments to mitigate occupational formaldehyde exposure levels proactively. These findings can be valuable for policymakers in the health sector, aiding in the elimination or reduction of airborne formaldehyde exposure in work environments,” the Iranian scientists wrote.

Managers of histology and clinical laboratories may find useful advice in hospital laboratory studies like that coming out of Iran. Protecting the health of lab workers worldwide starts with reducing their exposure to deadly chemicals.

—Kristin Althea O’Connor

Related Information:

Occupational Exposure, Carcinogenic and Non-Carcinogenic Risk Assessment of Formaldehyde in the Pathology Labs of Hospitals in Iran

National Academy of Sciences Confirms That Formaldehyde Can Cause Cancer in a Finding That Has Implications for Anatomic Pathology and Histology Laboratories

Pathology Lab Loses Accreditation Because of High Levels of Formaldehyde

Health of Pathology Laboratory Technicians at Risk from Common Solvents like Xylene and Toluene

NTRL Report on Carcinogens. Twelfth Edition, 2011

Two Big Anatomic Pathology Groups Will Merge in Washington State

Goal is to maintain community pathology services while expanding subspecialty pathology expertise to offer more laboratory testing services to physicians

Two of Washington State’s largest anatomic pathology  groups announced their intention to merge earlier this week. When completed, the combined pathology supergroup will number 36 board-certified pathologists and will have large histology laboratories in both the western and eastern regions of Washington.

The merger will bring together the pathologists of InCyte Pathology of Spokane with Eastside Pathology Incorporated of Bellevue. Although InCyte has 25 pathologists and Eastside has 11 pathologists, leaders at both pathology groups told Dark Daily that each group considers this a merger of equals. This is one key to understanding why this merger is happening. (more…)

Even in New Hampshire, There is Increased Competition for Clinical Pathology Laboratory Test Referrals

Clinical laboratory outreach program at Catholic Medical Center sees new lab competitors entering the Manchester market

DATELINE: MANCHESTER, NEW HAMPSHIRE—Here in the Granite State, clinical laboratories and pathology groups must respond to a growing number of healthcare market trends. This was obvious to your Dark Daily Editor during his site visit earlier this week to the medical laboratory at Catholic Medical Center, which is one of Manchester’s major hospitals.

Often, states with relatively small populations, like New Hampshire, Vermont, and Maine, have the luxury of watching the latest healthcare trends emerge first in the major urban centers like Boston, New York, and Philadelphia. However, the accelerating pace of change across all of healthcare is changing that situation.

In Manchester, New Hampshire, competition among hospitals in the community is quite intense. According to Roberta E. Provencal, Director of Laboratory Services at Catholic Medical Center, there is equally intense competition in the outreach market for both clinical laboratory testing and anatomic pathology services. “Manchester has about 110,000 people, and there are 1.3 million in all of New Hampshire,” observed Provencal. “Yet, even though these are not large healthcare markets, we have more lab competitors marketing to doctors’ offices in our city than at any time in the past 20 years. (more…)

Revisiting the Clinical Pathology Lab’s Problem of Floaters and Other Contaminates

As automation transforms the manual work processes in the histopathology laboratory, “floaters” may become a thing of the past

Any histotechnologist and pathologist familiar with the manual work processes commonly in use in histopathology laboratories knows about “floaters.” These are the pesky artifacts that are a consequence of the common practice of manually processing tissue through the series of H&E linear baths required for the proper staining of these samples prior to analysis by anatomic pathologists.

“Floaters” are a relevant example of why manual work processes in the histopathology laboratory can be the source of errors and mistakes. Certain types of floaters—including floaters consisting of malignant tissue fragments—have the potential to contaminate the patient specimen. This can negatively impact patient safety and even contribute to a misdiagnosis of the patient. Moreover, the issue of floaters has been around for decades, because the manual work processes involving the H&E (hematoxylin and eosin stain) linear baths have remained relatively unchanged during this time.

(more…)

In Italy, Visinoni’s Vision of “Patient First” Anatomic Pathology Services

Applying principals of analytic chemistry to advance value of histopathology

In Bergamo, Italy, a vision of “patient first” anatomic pathology is under construction in a unique way. At the corporate headquarters of Milestone Medical, Founder, President and self styled “Chief Dreamer” Franco Visinoni is actively investing to develop pre-analytical tools and products specifically designed to support same day—or faster—diagnoses by pathologists.

This week, your Dark Daily Editor Robert L. Michel visited Visinoni in Bergamo to learn, first-hand, about this company which has a rather low profile in the United States.
(more…)

;